1. Scrip
  2. >>Business

Sanofi Teams With US Military On Zika, But Not For The Profits

 
• By Donna Young

Sanofi Pasteur has entered into an agreement with the US Walter Reed Army Institute of Research, part of the Department of Defense, to develop a Zika vaccine. But the company said it's not doing it for any potential profits, but has a "moral imperative" to respond to the epidemic.

SC1607_Zika_WalterReed-WRAIR_1200

It's never easy trying to convince the commercial side of a biopharmaceutical business why a company should go down the path of pursuing a product that may have great value in saving lives and preventing the spread of disease, but in the end, may not garner big profits.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Zelluna Believes Its TCR Tech Can Unlock Natural Killer Cell Potential

 
• By Andrew McConaghie

While CAR-NKs have pivoted towards autoimmune disease, the Norwegian biotech believes its unique platform can deliver in oncology

AstraZeneca COPD Drug Breztri Breezes Through Asthma Trials

 
• By Kevin Grogan

The triple therapy improves lung function in the Phase III KALOS and LOGOS studies

Transient FY26 For Syngene But Momentum In China +1 Projects

 
• By Anju Ghangurde

As biopharma derisks its business with China ‘rebalancing’ strategies, Syngene could convert majority of such pilots into full program contracts amid a challenging FY2025. The CRDMO also expects business discussions pertaining to a newly acquired US biologics site to mature into commercial opportunities.